VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 101 filers reported holding VERSARTIS INC in Q2 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $31,000 | -39.2% | 22,472 | -11.4% | 0.00% | – |
| Q2 2018 | $51,000 | -94.8% | 25,372 | -95.8% | 0.00% | – |
| Q1 2018 | $986,000 | -16.4% | 597,304 | +11.1% | 0.00% | – |
| Q4 2017 | $1,180,000 | -46.5% | 537,604 | -40.3% | 0.00% | – |
| Q3 2017 | $2,206,000 | -77.3% | 900,771 | +61.8% | 0.00% | -100.0% |
| Q2 2017 | $9,716,000 | -12.6% | 556,718 | +6.9% | 0.00% | 0.0% |
| Q1 2017 | $11,118,000 | +67.5% | 520,761 | +16.8% | 0.00% | 0.0% |
| Q4 2016 | $6,638,000 | +42.9% | 445,716 | +17.5% | 0.00% | – |
| Q3 2016 | $4,646,000 | +18.1% | 379,266 | +6.6% | 0.00% | – |
| Q2 2016 | $3,935,000 | +41.2% | 355,893 | +2.4% | 0.00% | – |
| Q1 2016 | $2,787,000 | -29.6% | 347,718 | +8.8% | 0.00% | – |
| Q4 2015 | $3,959,000 | +9.8% | 319,564 | +2.1% | 0.00% | – |
| Q3 2015 | $3,605,000 | +1.4% | 312,996 | +34.0% | 0.00% | – |
| Q2 2015 | $3,555,000 | +90.9% | 233,561 | +130.4% | 0.00% | – |
| Q1 2015 | $1,862,000 | +20.5% | 101,367 | +47.2% | 0.00% | – |
| Q4 2014 | $1,545,000 | +24.1% | 68,872 | +5.3% | 0.00% | – |
| Q3 2014 | $1,245,000 | -31.4% | 65,382 | +1.1% | 0.00% | – |
| Q2 2014 | $1,815,000 | – | 64,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
| Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
| Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
| Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
| HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
| Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
| RA Capital Management | 231,267 | $5,192,000 | 0.56% |
| Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
| PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |